Abstract-Effect of YM-
However, the efficacies of norepinephrine, phenylephrine and naphazoline were high in the aorta.
The dose-response curves for three alpha, -agonists were shifted by YM-12617 in a parallel manner in the aorta. The curves of norepine phrine and phenylephrine were also shifted by YM-1 2617 in the portal vein, where the efficacies of both the alpha, -agonists were high. The present results suggest that the mode of antagonism between the alphas -agonist and alpha, -antagonist is dependent on the efficacy of the alpha, -agonist which depends upon the receptor density in the organ used.
A number of alpha, -adrenoceptor agonists and -antagonists have been de veloped. They compete with each other for the alpha, -adrenoceptors.
If we plot a log dose-response curve for the alpha, -agonist in the presence of the alpha, -antagonist, it is shifted to higher doses in a parallel manner. These phenomena were reported in isolated organs such as vasa deferentia from the guinea pig and rat, aortae from the rabbit and rat, and rabbit pulmonary artery (1-5). There are, however, kinetic conditions under which competitive antagonists shift the dose-response curves of agonists to higher doses, but also depress the maximum responses. These phenomena are encountered with persistent (low rate of off set) an tagonists and low efficacy agonists, and they were described by Paton and Rang (6), Paton and Waud (7) and Kenakin (8) between an agonist and an antagonist, the preparations were pre treated with the antagonist for 30 min, and the dose-response curve of the agonist was obtained in the presence of the antagonist. The competitive antagonistic activity of the drug was expressed as the pA2-value, which is the negative logarithm of the dissociation constant, KB, of the antagonist. The pA2 value was estimated by the method of Arunlakshana and Schild (11) .
In some experiments, the dose-response curves for the agonists declined in the presence of YM 12617. These phenemena were thought to be the hemi-equilibrium state between the agonist, antagonist and receptors as reported by Paton and Rang (6) and Paton and Waud (7) . An estimate of the dissociation constant (KB) of the antagonist was made using the following equation I (6) :
where (12) . After the determination of the control dose response curves for the agonists, the pre parations were incubated with phenoxy benzamine (10-7 M) for 10 min. The pre parations were then allowed to equibrate for 60 min with repeated washing every 10 min, and second dose-response curves for the agonists were determined. The dissociation constant (KA) was calculated from the following equation IV: 
Results
In the aorta, all the dose-response curves for norepinephrine, phenylephrine and naphazoline were parallelly shifted to higher doses by prazosin and YM-1 2617, indicating a competitive antagonism. In the portal vein, the dose-response curves for norepinephrine and phenylephrine were also shifted by prazosin and YM-1 2617 in a parallel manner (Fig. 1) . The curve for naphazoline obtained in the portal vein was, however, shifted by prazosin and declined in the presence of YM-12617.
YM-12617 declined the dose response curves for norepinephrine and phenylephrine in the femoral vein, which were parallelly shifted by prazosin (Fig. 2) .
As the response of the femoral vein to naphazoline was too small to estimate precisely, the effects of the alpha, -blockers were not tested. The pA2-values for prazosin and YM-12617 were calculated from the parallel shifts of the curves for the alpha, agonists, since the slopes of the Schild plot were not different from unity (P<0.05), and these are summarized in Table 1 . The negative logarithm of the dissociation constant, pKA, of YM-12617 calculated by the equation I of Paton and Rang (6) was also summarized in Table 1 . A difference between the pA2 values for YM-12617 and prazosin was 1.0 to 1.7, suggesting that YM-1 2617 was 10 to 50 times as potent as prazosin. There is, however, no difference between the respec tive pA2-value for YM-12617 and prazosin estimated in different organs ( Table 1) . The efficacy and pKA-value (a negative log of KA) calculated by the method of Furchgott (12) are summarized in Table 2 . The efficacy of phenylephrine and norepine phrine in the femoral vein and that of naphazoline in the portal vein were less than 2, suggesting that the alpha, -stimulants used behaved as partial agonists in these organs. (Table  1) indicates that YM-12617 is a potent alpha, -adrenoceptor antagonist, as reported previously (9, 13) .
Discussion
In the organs such as the femoral vein and portal vein, where alpha,-receptor stimulants behaved as low efficacy agonists, the potent alpha, -antagonist YM-12617 shifted their dose-response curves to the right and also depressed the maximum response. These phenomena are considered to be the hemi equilibrium state (6) (7) (8) .
It is known that under the hemi-equilibrium state the antagonist behaves as an essentially ir reversible blocker and produces unsurmoun table antagonism.
The depression of the maximal response for any given dose ratio is dependent upon the efficacy of the agonist (6) (7) (8) . According to Paton's rate theory (14) , the rate constant for dissociation of a potent competitive antagonist is smaller than that of a less potent antagonist, that is, the potent antagonist forms a complex with the receptor which is slowly broken up. YM-12617 is thought to dissociate more slowly from the alpha, -adrenoceptor than prazosin. Therefore the hemiequilibrium state was observed in the experiments with YM-12617, but not in those with prazosin. The depression of the concentration response curves of guinea pig ilea) longitudinal muscles to noctyltrimethyl ammonium by hyoscine was already reported by Rang (15) . Using the equation I, Rang (15) calculated the dissciation constant KB for hyoscine with noctyltrimethylammonium and found that it agreed with independent estimates by hyoscine antagonism of methyl furmethide. These results coincide with the present obsevations that the pA2 value (the negative logarithm of K,3) for YM-12617 estimated from the Schild plot was equal to the negative logarithm of KB calculated by the equation I of Paton and Rang (6) According to Furchgott (12) , the efficacy is dependent on the receptor-density in the organ used. The present results indicate that the mode of antagonism between the agonist and an tagonist is dependent upon the efficacy of the agonist which depends upon the receptor-density in the organ used, although it is necessary to estimate the receptor density.
